Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL [Phase 2]
A Phase 2 clinical trial evaluating lenalidomide in combination with G-CHOP for newly diagnosed diffuse large B-cell lymphoma with follicula…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chidamide in combination with linperlisib for refractory/relapsed follicular lymphoma is currently recruit…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma [Phase 2]
Phase 2 trial of axicabtagene ciloleucel for relapsed/refractory follicular lymphoma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma [NA]
A prospective analysis of circulating nucleosomes in patients receiving first-line treatment for non-Hodgkin lymphoma, including Follicular …
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update on locally manufactured CAR T-cell products for multiple B-cell malignancies, including B-cell lymphoma and B-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial investigating Zuberitamab in combination with bendamustine, followed by maintenance, for treatment-naïve follicular…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: The Microbiome in Blood Cancer and HLH
A clinical trial update from University of Nottingham examining the microbiome's role in blood cancers and haemophagocytic lymphohistiocytos…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: MOLyF : Bone Marrow and Follicular Lymphoma [NA]
This entry reports a recruiting clinical trial named MOLyF addressing follicular lymphoma with bone marrow involvement, sponsored by Rennes …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody [Phase 3]
A Phase 3 trial is evaluating radiotherapy plus an anti-CD20 antibody for early-stage follicular lymphoma (WHO grade 1/2 or 3a). The study i…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma [Phase 3]
A Phase 3 trial evaluating MIL62 in combination with Lenalidomide versus Lenalidomide alone for rituximab-refractory follicular lymphoma is …
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating MIL62 plus lenalidomide for relapsed/refractory indolent non-Hodgkin's lymphoma (follicular lymphom…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 [Phase 3]
Phase 3 trial evaluating mosunetuzumab plus lenalidomide versus anti-CD20 antibody plus chemotherapy in follicular lymphoma (FLIPI2-5) is cu…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL) [Phase 2]
A Phase 2 trial evaluating a triplet regimen of zanubrutinib, obinutuzumab, and lenalidomide (ZGR) in high-risk, treatment-naive follicular …
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy [Phase 1, Phase 2]
Update on a Phase 1/Phase 2 study of tazemetostat in newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma treated with chem…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma [Phase 2]
Phase 2 study update describing Zanubrutinib in combination with Obinutuzumab for newly diagnosed follicular lymphoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma [NA]
Clinical trial update for indolent localized GI lymphomas using 20 Gy involved-site radiotherapy (ISRT); currently recruiting for gastric or…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
This clinical trial update from Adaptive Biotechnologies aims to optimize ctDNA-based minimal residual disease assessment in patients with f…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas [Phase 3]
This Phase 3 trial update discusses how the duration of rituximab maintenance therapy may affect outcomes in various non-Hodgkin lymphomas, …
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers [Phase 1, Phase 2]
Phase I/IIa clinical trial update for BR1733 in advanced cancers, including follicular lymphoma, peripheral T-cell lymphoma, and diffuse lar…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A [Phase 1]
This clinical trial update describes a Phase 1 study of combining nivolumab with rituximab as first-line therapy for follicular lymphoma (gr…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR [Phase 1, Phase 2]
A Phase 1/2 clinical trial at University Hospital Heidelberg is evaluating third-generation CD19-directed CAR T cells in relapsed or refract…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma [Phase 1, Phase 2]
This entry reports an ongoing Phase 1/2 clinical trial evaluating a triple-drug regimen of lenalidomide, venetoclax, and obinutuzumab in tre…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma [Phase 2]
This clinical trial update reports a Phase 2 study evaluating a combination of zanubrutinib, rituximab, and venetoclax in previously untreat…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma [NA]
This document provides an update on a clinical trial evaluating whole-body diffusion-weighted MRI for staging and predicting treatment respo…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma [Phase 2]
Phase 2 clinical trial evaluating zanubrutinib in combination with G-CHOP for untreated intermediate-high risk follicular lymphoma; study st…